Interferon-γ upregulates the c-Met/hepatocyte growth factor receptor expression in alveolar epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 4, 1999, Pages 490-497

  Nagahori, Toshifumi ^b   Dohi, Makoto ^a   Matsumoto, Kunio ^b   Saitoh, Kazuko ^b   Honda, Zen Ichiro ^b   Nakamura, Toshikazu ^b   Yamamoto, Kazuhiko ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; CHEMOTAXIS; DRUG EFFECT; EPITHELIUM CELL; GENETICS; HUMAN; INJURY; LUNG; LUNG ALVEOLUS; LUNG FIBROSIS; MALE; METABOLISM; MOUSE; PROTO ONCOGENE; UPREGULATION;

ANIMALS; CELL LINE; CHEMOTAXIS; EPITHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LUNG; MALE; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-MET; PROTO-ONCOGENES; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RNA, MESSENGER; UP-REGULATION;

EID: 0033208681     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.4.3614     Document Type: Article

References (55)

1. Liebow, A. A. 1975. Definition and classification of interstitial pneumonias in human pathology. In Progress in Respiration Research, Vol. 8: Alveolar Interstitium of the Lung. F. Basset and R. Georges, editors. S. Karger, Basel. 1-33.
2. Crystal, R. G., J. D. Fulmer, W. C. Roberts, M. L. Moss, B. R. Line, and H. Y. Reynolds. 1976. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann. Intern. Med. 85:769-788.
3. McDonald, J. A., and C. Kuhn III. 1993. Fibroblasts and collagen deposition in interstitial lung disease. In Interstitial Lung Disease. M. I. Schwartz and T. King, Jr., editors. Blackwell Science Ltd., Hamilton, Canada. 45-56.
4. McDonald, J. A. 1991. Idiopathic pulmonary fibrosis: a paradigm for lung injury and repair. Chest 99:875-935.
5. Mason, R. J., and M. C. Williams. 1977. Type II alveolar cell: defender of the alveolus. Am. Rev. Respir. Dis. 115:81-91.
6. Adamson, I. Y. R., L. Young, and D. H. Bowden. 1988. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol. 130:377-383.
7. Nakamura, T., K. Nawa, and A. Ichihara. 1984. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122:1450-1459.
8. Nakamura, T., K. Nawa, A. Ichihara, N. Kaise, and T. Nishino. 1987. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224:311-316.
9. Nakamura, T., T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, and S. Shimizu. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443.
10. Nakamura, T. 1991. Structure and function of hepatocyte growth factor. Prog. Growth Factor Res. 3:67-86.
11. Montesano, R., K. Matsumoto, T. Nakamura, and L. Orci. 1991. Identification of the fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901-908.
12. Soriano, J. V., M. S. Pepper, T. Nakamura, L. Orci, and R. Montesano. 1995. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell. Sci. 108:413-430.
13. Barros, E. J., O. F. Santos, K. Matsumoto, T. Nakamura, and S. K. Nigam. 1995. Differential tubulogenic and branching morphogenic activities of growth factors. Proc. Natl. Acad. Sci. USA 92:4412-4416.
14. Zarnegar, R., and G. K. Michalopoulos. 1995. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 129:1177-1180.
15. Bottaro, D. P., J. S. Rubin, D. L. Falletto, A. M.-I. Chan, T. E. Kmiccik, G. F. Vande Woude, and S. A. Aaronson. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804.
16. Naldini, L., E. Vigna, R. P. Narcimham, G. Gaudino, R. Zarneger, G. K. Michalopoulos, and P. M. Comoglio. 1991. Hepatocyte growth factor stimulates the tyrosine kinase activity of the receptor encoded by the protooncogene c-Met. Oncogene 6:501-510.
17. Ishiki, Y., H. Ohnishi, Y. Muto, K. Matsumoto, and T. Nakamura. 1992. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16: 1227-1235.
18. Matsuda, Y., K. Matsumoto, T. Ichida, and T. Nakamura. 1995. Hepatocyte growth factor suppresses the onset of the liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J. Biochem. 118:643-649.
19. Igawa, T., T. Matsumoto, T. Ichida, and T. Nakamura. 1993. Hepatocyte growth factor may function as a renotrophic factor for regeneration in rats with acute renal injury. Am. J. Physiol. 265:F61-F69.
20. Kawaida, K., K. Matsumoto, H. Shimazu, and T. Nakamura. 1994. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. USA 91:4357-4361.
21. Mason, R. J., C. C. Leslie, K. McCormik-Shannon, R. K. Deterding, T. Nakamura, J. S. Rubin, and J. M. Shannon. 1994. Hepatocyte growth factor is a growth factor tor rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 11:561-567.
22. Shiratori, M., G. Michalopoulos, H. Shinozuka, G. Singh, H. Ogasawara, and S. L. Katyal. 1995. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro. Am. J. Respir. Cell Mol. Biol. 12:171-180.
23. Yanagita, K., K. Matsumoto, K. Sekiguchi, H. Ichibayashi, Y. Niho, and T. Nakamura. 1993. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 268:21212-21217.
24. Yaekashiwa, M., S. Nakayama, K. Ohnuma, T. Sakai, T. Abe, K. Satoh, K. Matsumoto, T. Nakamura, J. Takahashi, and T. Nukiwa. 1997. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. Am. J. Respir. Crit. Care Med. 156:1937-1944.
25. Car, B. D., F. Meloni, and M. Luisetti. 1994. Elevated IL-8 and MCP-1 in BAL fluid of patients with IPF and pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 149:655-659.
26. Grigris, R. E., M. A. Basha, and M. Maliarik. 1995. Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 152:71-75.
27. Jones, K. P., S. P. Reynolds, and S. J. Capper. 1991. Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung diseases and control subjects. Clin. Exp. Immunol. 83:30-34.
28. Gauldie J., M. Jordana, and G. Cox. 1993. Cytokines and pulmonary fibrosis. Thorax 48:931-935.
29. Lesur, O., K. Arsalane, and D. Lane. 1996. Lung alveolar epithelial cell migration in vitro: modulators and regulation processes. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14):L311-L319.
30. Cooper, C. S., M. Park, D. G. Blair, M. A. Tainsky, K. Huebner, C. M. Croce, and G. F. Vande Woude. 1984. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311: 29-33.
31. Park, M., M. Dean, C. S. Cooper, M. Schmidt, S. J. O'Brien, D. G. Blair, and G. F. Vande Woude. 1986. Mechanism of met oncogene activation. Cell 45:895-904.
32. Park, M., M. Dean, K. Kaul, M. J. Braun, M. Gonda, and G. F. Vande Woude. 1987. Sequence of MET proto-oncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84:6379-6383.
33. Chan, A. M., H. W. S. King, E. A. Deakin, P. R. Tempest, J. Hilkens, V. Kroezen, D. R. Edwards, A. J. Wills, P. Brooks, and C. S. Cooper. 1988. Characterization of the mouse met proto-oncogene. Oncogene 2:593-599.
34. Tempest, P. R., M. R. Stratton, and C. S. Cooper. 1988. Structure of the met protein and variation of met protein kinase activity among human tumor cell lines. Br. J. Cancer 58:3-7.
35. Iyer, A., T. Kmiccik, M. Park, I. Dear, P. Blair, K. J. Dunn, P. Strave, J. Ihle, M. Bodescot, and G. F. Vande Woude. 1990. Structure, tissue-specific expression, and transforming activity of the mouse met proto-oncogene. Cell Growth Differ. 1:87-95.
36. Kan, M., G. H. Zhang, R. Zarnegar, G. K. Michalopoulos, Y. Myoken, W. McKeehan, and J. L. Stevens. 1991. Hepatocyte growth factor/hepatoprotein A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenehymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. Biochem. Biophys. Res. Commun. 174:331-337.
37. Matsumoto, K., H. Tajima, and T. Nakamura. 1991. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem. Biophys. Res. Commun. 176:45-51.
38. Rubin, J. S., A. M. L. Chan, D. P. Bottaro, W. H. Burgess, W. G. Taylor, A. C. Cech, D. W. Hirschfield, J. Wong, R. Miki, P. W. Finch, and S. A. Aaronson. 1991. A broad-spectrum human lung fibroblast-derived mitogen is a varient of hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 88:415-419.
39. Sakai, T., K. Satoh, K. Matsushima, S. Shindo, S. Abe, T. Abe, M. Motomiya, T. Kawamoto, Y. Kawabata, T. Nakamura, and T. Nukiwa. 1997. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am. J. Respir. Cell Mol. Biol. 16:388-397.
40. Maeda, J., N. Ueki, T. Hada, and K. Higashino. 1995. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am. J. Respir. Crit. Care Med. 152:1587-1591.
41. Trinchieri, G., and B. Perssia. 1985. Immune interferon: a pleiotrophic lymphokine with multiple effects. Immunol. Today 6:131-136.
42. Bitterman, P. B., M. D. Wewers, S. I. Rennard, S. Adelberg, and R. G. Crystal. 1986. Modulation of the alveolar driven fibroblast proliferation by alternative macrophage mediators. J. Clin. Invest. 77:700-708.
43. Hunninghake, G. W., C. Hemken, M. Brady, and M. Monick. 1986. Immune interferon is a growth factor for human lung fibroblasts. Am. Rev. Respir. Dis. 134:1025-1028.
44. Crouch, E. 1990, Pathology of pulmonary fibrosis. Am. J. Physiol. 259:L159-L184.
45. Saunders, N. A., R. J. Smith, and A. M. Jetten. 1994. Differential responsiveness of human bronchial epithelial cells, lung carcinoma cells, and bronchial fibroblasts to interferon-γ in vitro. Am. J. Respir. Cell Mol. Biol. 11:147-152.
46. Thompson, D. C., S. E. Porter, A. K. Bauer, K. C. Das, B. Ou, L. Dwyer-Nield, C. W. White, and A. M. Malkinson. 1998. Cytokine-induced nitric oxide formation in normal but not in neoplastic murine lung epithelial cell lines. Am. J. Physiol. 274(6, Pt. I):L922-L932.
47. Moghul, A., L. Lin, A. Beedle, A. Kanbour-Shakir, M. C. DeFrances, Y. Liu, and R. Zarnegar. 1994. Modulation of c-Met proto-oncogene (IIGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of 8kb c-Met transcript. Oncogene 9:2045-2052.
48. Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18:29-43.
49. Matsumoto, K., H. Tajima, H. Okazaki, and T. Nakamura. 1992. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β1 and glucocorticoids. J. Biol. Chem. 267:24917-24920.
50. Sempowski, G. D., S. Derdak, and R. P. Phipps. 1996. Interleukin-4 and interferon-γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J. Cell. Physiol. 167:290-296.
51. Darnel, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science 264:1415-1421.
52. Ihle, J. N., B. A. Witthuhun, F. W. Quelle, K. Yamamoto, and O. Silvennoinen, 1995. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 7:145-173.
53. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-334.
54. Shyu, A. B., M. Grenberg, and J. G. Belasco. 1989. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Geness Dev. 3:70-72.
55. Chen, Y. P., T. E. Toole, T. Shipley, J. Forsyth, S. E. LaFlamme, K. M. Yamada, S. J. Shattil, and M. H. Ginsberg. 1994. "Inside-out" signal transduction inhibited by isolated integrin cytoplasmic domains. J. Biol. Chem. 269:18307-18310.